A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving ...

Researchers at Dartmouth Hitchcock Medical Center have developed a way to diagnose Lyme disease earlier and more accurately ...

The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early ...

Cancer research, drug safety testing and aging biology may all gain a major boost from a new fluorescent sensor developed at ...

Advanced in organs on chips, digital twins, and AI are ushering in a new era of research and drug development.

The clock is up on Biogen’s extra two years of a biosimilar-free U.S. market for its blockbuster multiple sclerosis (MS) med ...

The Diagnostic Labs Market is poised for growth due to rising chronic disease prevalence, aging populations, and advancements in technology. Key opportunities include leveraging AI for better data ...

Cancer research, drug safety testing and ageing biology may all gain a major boost from a new fluorescent sensor developed at ...

Sandoz announced that Tyruko (natalizumab-sztn), a biosimilar of Biogen Idec’s Tysabri, is available to patients in the ...

Scientists are trying a revolutionary new approach to treat rheumatoid arthritis, multiple sclerosis, lupus and other ...